To Evaluate the Performance and Safety of YVOIRE Volume Plus for Improvement of Mid-face Volume

Midface Volume Deficit Clinical Trial

Official title:
A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Design Investigation to Evaluate Performance and Safety of YVOIRE Volume Plus Versus Restylane Lyft With Lidocaine for Temporary Improvement of Mid-face Volume

Status Active, not recruiting

Clinical Trial Summary

A Study to Evaluate the Performance and Safety of YVOIRE volume plus for Temporary Improvement of Mid-face Volume

Clinical Trial Description

This is a Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Design Investigation to Evaluate the Performance and Safety of YVOIRE volume plus versus Restylane Lyft with Lidocaine for Temporary Improvement of Mid-face Volume. ;

Study Design

Related Conditions & MeSH terms

Midface Volume Deficit

Clinical Trial Details

NCT number	NCT04784299
Study type	Interventional
Source	LG Chem
Contact
Status	Active, not recruiting
Phase	N/A
Start date	March 22, 2021
Completion date	October 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04971876` - Evaluation of the Safety and Performance of an Injectable Hyaluronic Acid Filler	N/A
Active, not recruiting	`NCT04132518` - Sculptra for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A
Completed	`NCT03532126` - A 52-week Clinical Investigation of Princess® VOLUME PLUS Lidocaine in Subjects With Midface Volume Deficit
Completed	`NCT03289052` - Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A
Completed	`NCT03097783` - Restylane Perlane Lidocaine for Correction of Midface Volume Deficit and/or Midface Contour Deficiency	N/A